Skip to main content
. 2020 Mar 4;9(3):613. doi: 10.3390/cells9030613

Figure 5.

Figure 5

SCO-201 inhibited drug-stimulated ATPase activity of BCRP. (A) The effect of increasing concentrations of SCO-201 on basal and sulfasalazine-stimulated ATPase activity of BCRP. The data are indicated as relative ATPase activity, normalized with respect to basal (untreated) and maximal (sulfasalazine-stimulated) ATPase activity of BCRP. Sulfasalazine alone resulted in a maximal ATPase activity of 104.8 nmol Pi/mg protein/min compared to the baseline activity of 50.68 nmol Pi/mg protein/min. (B,C) The effect of 0.5 µM (B) and 1.5 µM (C) SCO-201 on SN-38-stimulated ATPase activity of BCRP. Error bars on all graphs represent SD determined from duplicates.